Filana Therapeutics Inc (FLNA)

$1.40 +0.04 (2.94%)
Market Cap 65.70M
Revenue (ttm) 0.00
Net Income (ttm) -90.97M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 198,600
Avg Vol 399,624
Day's Range N/A - N/A
Shares Out 48.31M
Stochastic %K 39%
Beta -0.71
Analysts Strong Sell
Price Target $6.50

Company Profile

Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is in Phase 3 clinical trial to treat Alzheimer's disease; and investigational diagnostic product candidate is SavaDx, an early-stage program focused on detecting the presence of Alzheimer's disease from a small sample of blood. The company was formerly known as Cassava Sciences, Inc. and changed its na...

Industry: Biotechnology
Sector: Healthcare
Phone: 512 501 2444
Address:
6801 N. Capital of Texas Highway, Building 1, Austin, United States
Wellthen
Wellthen Jun. 4 at 8:11 PM
$FLNA I think given even modest results from the studies, simufulam should be submitted for Expanded Access — compassionate use as people have no real alternative and their is some proof it works. Also, has there been any follow up on long term users? Once any indication for this drug is approved, it will be the largest off-label drug in history.
0 · Reply
fedeperu
fedeperu May. 29 at 8:00 PM
$FLNA when will we see 10 $ again?
3 · Reply
theoptionsplug
theoptionsplug May. 28 at 10:38 PM
$FLNA broke out of a massive daily wedge recently and today closed RIGHT on its 50 DMA. If we see a daily close over 1.55 tomorrow, this can go on a crazy run 📈
0 · Reply
GangsterX
GangsterX May. 28 at 6:11 PM
$FLNA filled 1.50 quietly .. small position
0 · Reply
fedeperu
fedeperu May. 28 at 6:08 PM
$FLNA 👀👀
0 · Reply
iaconi
iaconi May. 27 at 5:41 PM
$FLNA there is a big accumulation on 1,5$ !
0 · Reply
Bricktop200
Bricktop200 May. 27 at 11:38 AM
$FLNA blue skies ahead.
2 · Reply
Guitars7
Guitars7 May. 26 at 11:27 PM
$FLNA over 50 k watchers… one of highest… Everyone sitting on sidelines waiting for a major catalyst
1 · Reply
Iam4our
Iam4our May. 26 at 9:19 PM
$FLNA Shall we continue $1.66? ✅
0 · Reply
bobbythek
bobbythek May. 26 at 8:16 PM
$FLNA Maxim out with new $5 price target...
0 · Reply
Latest News on FLNA
Filana Therapeutics resumed with Buy at Maxim on rebranding, strategic pivot

2026-05-26T13:58:44.000Z - 9 days ago

Filana Therapeutics resumed with Buy at Maxim on rebranding, strategic pivot

Filana Therapeutics resumed with a Buy at Maxim

2026-05-26T12:40:15.000Z - 9 days ago

Filana Therapeutics resumed with a Buy at Maxim

Filana Therapeutics Reports Q1 2026 Financial Results and Business Update

May 7, 2026, 8:00 AM EDT - 4 weeks ago

Filana Therapeutics Reports Q1 2026 Financial Results and Business Update

Filana Therapeutics Earnings release: Q1 2026

May 7, 2026, 8:00 AM EDT - 4 weeks ago

Filana Therapeutics Earnings release: Q1 2026

Filana Therapeutics Quarterly report: Q1 2026

May 7, 2026, 8:00 AM EDT - 4 weeks ago

Filana Therapeutics Quarterly report: Q1 2026

Filana Therapeutics Slides: Corporate presentation

May 7, 2026, 7:00 AM EDT - 4 weeks ago

Filana Therapeutics Slides: Corporate presentation

Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII

May 5, 2026, 8:00 AM EDT - 4 weeks ago

Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII

Filana Therapeutics Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 5 weeks ago

Filana Therapeutics Proxy statement: Proxy filing

Filana Therapeutics publishes simufilam preclinical data

2026-04-15T12:20:15.000Z - 7 weeks ago

Filana Therapeutics publishes simufilam preclinical data

Filana Therapeutics management to meet with Maxim

2026-03-19T19:25:18.000Z - 2 months ago

Filana Therapeutics management to meet with Maxim

Filana Therapeutics reports Q4 EPS (26c) vs. (57c) last year

2026-03-12T12:13:27.000Z - 3 months ago

Filana Therapeutics reports Q4 EPS (26c) vs. (57c) last year

Filana Therapeutics sees 1H26 net cash use in operations $14M-$17M

2026-03-12T12:12:53.000Z - 3 months ago

Filana Therapeutics sees 1H26 net cash use in operations $14M-$17M

Filana Therapeutics Annual report: Q4 2025

Mar 12, 2026, 8:00 AM EDT - 3 months ago

Filana Therapeutics Annual report: Q4 2025

Filana Therapeutics Earnings release: Q4 2025

Mar 12, 2026, 8:00 AM EDT - 3 months ago

Filana Therapeutics Earnings release: Q4 2025

Filana Therapeutics Slides: Investor presentation

Mar 10, 2026, 7:00 AM EDT - 3 months ago

Filana Therapeutics Slides: Investor presentation

Cassava Sciences says US DOJ has closed investigation into company

Feb 19, 2026, 8:52 AM EST - 3 months ago

Cassava Sciences says US DOJ has closed investigation into company

HALPER SADEH LLC ENCOURAGES CASSAVA SCIENCES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Dec 24, 2025, 11:51 AM EST - 5 months ago

HALPER SADEH LLC ENCOURAGES CASSAVA SCIENCES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Filana Therapeutics Registration statement: Registration Filing

Nov 13, 2025, 7:00 AM EST - 7 months ago

Filana Therapeutics Registration statement: Registration Filing

Filana Therapeutics Quarterly report: Q3 2025

Nov 12, 2025, 8:00 AM EST - 7 months ago

Filana Therapeutics Quarterly report: Q3 2025

Filana Therapeutics Earnings release: Q3 2025

Nov 12, 2025, 8:00 AM EST - 7 months ago

Filana Therapeutics Earnings release: Q3 2025

Halper Sadeh LLC Encourages Cassava Sciences, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Oct 22, 2025, 4:05 PM EDT - 8 months ago

Halper Sadeh LLC Encourages Cassava Sciences, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Cassava Sciences Appoints Dawn C. Bir to the Board of Directors

Oct 22, 2025, 8:00 AM EDT - 8 months ago

Cassava Sciences Appoints Dawn C. Bir to the Board of Directors

Filana Therapeutics Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 8, 2025, 5:00 PM EDT - 9 months ago

Filana Therapeutics Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Filana Therapeutics Quarterly report: Q2 2025

Aug 14, 2025, 8:00 AM EDT - 10 months ago

Filana Therapeutics Quarterly report: Q2 2025

Filana Therapeutics Earnings release: Q2 2025

Aug 14, 2025, 8:00 AM EDT - 10 months ago

Filana Therapeutics Earnings release: Q2 2025

Cassava Reports Q2 2025 Financials Results and Provides Business Update

Aug 14, 2025, 7:30 AM EDT - 10 months ago

Cassava Reports Q2 2025 Financials Results and Provides Business Update

Cassava Sciences Appoints Dr. Joseph Hulihan as Chief Medical Officer

Aug 7, 2025, 7:30 AM EDT - 10 months ago

Cassava Sciences Appoints Dr. Joseph Hulihan as Chief Medical Officer

Cassava Sciences Reports Positive Preclinical Study Evaluating Simufilam for TSC-Related Epilepsy

Aug 4, 2025, 7:30 AM EDT - 10 months ago

Cassava Sciences Reports Positive Preclinical Study Evaluating Simufilam for TSC-Related Epilepsy

Cassava Presents Promising Preclinical Simufilam Data at TSC Alliance Meeting

Jun 30, 2025, 7:00 AM EDT - 1 year ago

Cassava Presents Promising Preclinical Simufilam Data at TSC Alliance Meeting

Filana Therapeutics Quarterly report: Q1 2025

May 8, 2025, 7:00 AM EDT - 1 year ago

Filana Therapeutics Quarterly report: Q1 2025

Filana Therapeutics Earnings release: Q1 2025

May 8, 2025, 7:00 AM EDT - 1 year ago

Filana Therapeutics Earnings release: Q1 2025

Cassava Appoints Angélique Bordey, PhD, to Enhance Preclinical Program in TSC

May 1, 2025, 7:30 AM EDT - 1 year ago

Cassava Appoints Angélique Bordey, PhD, to Enhance Preclinical Program in TSC

Cassava Announces Retirement of Chief Medical Officer, Dr. Jim Kupiec, and Appointment of Dr. Jack Moore as Senior Vice President, Clinical Development

Apr 21, 2025, 4:30 PM EDT - 1 year ago

Cassava Announces Retirement of Chief Medical Officer, Dr. Jim Kupiec, and Appointment of Dr. Jack Moore as Senior Vice President, Clinical Development

Filana Therapeutics Proxy statement: Proxy Filing

Apr 14, 2025, 8:00 AM EDT - 1 year ago

Filana Therapeutics Proxy statement: Proxy Filing

Filana Therapeutics Proxy statement: Proxy Filing

Apr 3, 2025, 8:00 AM EDT - 1 year ago

Filana Therapeutics Proxy statement: Proxy Filing

Cassava Sciences must face malicious prosecution lawsuit over Alzheimer's drug

Mar 26, 2025, 3:49 PM EDT - 1 year ago

Cassava Sciences must face malicious prosecution lawsuit over Alzheimer's drug

Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data

Mar 25, 2025, 8:05 AM EDT - 1 year ago

Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data

Cassava Sciences Reports 2024 Financial Results and Provides Business Update

Mar 3, 2025, 7:30 AM EST - 1 year ago

Cassava Sciences Reports 2024 Financial Results and Provides Business Update

Filana Therapeutics Annual report: Q4 2024

Mar 3, 2025, 7:30 AM EST - 1 year ago

Filana Therapeutics Annual report: Q4 2024

Filana Therapeutics Earnings release: Q4 2024

Mar 3, 2025, 7:30 AM EST - 1 year ago

Filana Therapeutics Earnings release: Q4 2024

Cassava Sciences Provides a Business Update

Jan 7, 2025, 4:30 PM EST - 1 year ago

Cassava Sciences Provides a Business Update

Wellthen
Wellthen Jun. 4 at 8:11 PM
$FLNA I think given even modest results from the studies, simufulam should be submitted for Expanded Access — compassionate use as people have no real alternative and their is some proof it works. Also, has there been any follow up on long term users? Once any indication for this drug is approved, it will be the largest off-label drug in history.
0 · Reply
fedeperu
fedeperu May. 29 at 8:00 PM
$FLNA when will we see 10 $ again?
3 · Reply
theoptionsplug
theoptionsplug May. 28 at 10:38 PM
$FLNA broke out of a massive daily wedge recently and today closed RIGHT on its 50 DMA. If we see a daily close over 1.55 tomorrow, this can go on a crazy run 📈
0 · Reply
GangsterX
GangsterX May. 28 at 6:11 PM
$FLNA filled 1.50 quietly .. small position
0 · Reply
fedeperu
fedeperu May. 28 at 6:08 PM
$FLNA 👀👀
0 · Reply
iaconi
iaconi May. 27 at 5:41 PM
$FLNA there is a big accumulation on 1,5$ !
0 · Reply
Bricktop200
Bricktop200 May. 27 at 11:38 AM
$FLNA blue skies ahead.
2 · Reply
Guitars7
Guitars7 May. 26 at 11:27 PM
$FLNA over 50 k watchers… one of highest… Everyone sitting on sidelines waiting for a major catalyst
1 · Reply
Iam4our
Iam4our May. 26 at 9:19 PM
$FLNA Shall we continue $1.66? ✅
0 · Reply
bobbythek
bobbythek May. 26 at 8:16 PM
$FLNA Maxim out with new $5 price target...
0 · Reply
jerrik
jerrik May. 26 at 5:39 PM
$FLNA https://www.tipranks.com/news/the-fly/filana-therapeutics-resumed-with-a-buy-at-maxim-thefly-news
0 · Reply
Swai
Swai May. 26 at 2:25 PM
$FLNA - Best guess is the tutes caught wind of the hold being lifted. Unless they pull a rabbit out of a hat, Idk what else this could be. Maxim also covering this 🤨
0 · Reply
Bricktop200
Bricktop200 May. 26 at 2:07 PM
$FLNA it’s been a good day
2 · Reply
whydididothat
whydididothat May. 26 at 1:47 PM
$FLNA knew I should’ve grabbed those $1.18
1 · Reply
whydididothat
whydididothat May. 26 at 1:42 PM
$FLNA 2.54
0 · Reply
Bricktop200
Bricktop200 May. 26 at 10:11 AM
$FLNA but yet here he is lurking around the board like a bitter ex.
0 · Reply
Milton22
Milton22 May. 25 at 3:34 PM
$FLNA I lost millions on SAVA… I cannot imagine ever getting sucked into this again
0 · Reply
Albogen
Albogen May. 25 at 10:23 AM
$FLNA big bounce incoming soon!
1 · Reply
Bricktop200
Bricktop200 May. 20 at 6:36 PM
$FLNA I feel this will move.
1 · Reply
Chrissytina
Chrissytina May. 20 at 6:09 PM
$FLNA Here…it…comes!!!
0 · Reply
iaconi
iaconi May. 19 at 6:04 PM
$FLNA is this the floor until the news they sent the data to FDA?
0 · Reply
pi828
pi828 May. 16 at 1:45 AM
$FLNA my portfolio hasn't recovered from Remi and his athletic wife. I recently moved the money to $MDAI. Hopefully, that works out. Any idea what Remi and Linda are doing? I used to attack the PHds who said the whole thing was a scam. Including the Chinese researcher. They were so right.
2 · Reply